biotechstockdaily.bsky.social
We focus on emerging healthcare companies shaping the future of medicine, biotechnology, diagnostics, and life sciences. https://biotechstockdaily.com/
👤 Joined on 07 June 2026
Followers
Following
Total Posts
@biotechstockdaily.bsky.socialPhase 3 ACHIEVE-4: Lilly's oral GLP-1 Foundayo showed no added heart risk vs. insulin glargine in type 2 diabetes, with better A1C and weight results. #Biotech #Diabetes #Discovery Disclaimer: This is NOT a financial advice
Show PostCounterfeit cigarettes are an increasingly lucrative market for organized crime in Europe, offering a better risk-reward ratio than trafficking cocaine. See how secret factories churning out fakes are causing a headache for the authorities: bloom.bg/3Vw88h3 📷️: Cyril Marcilhacy/Bloomberg
Show PostActinium Pharmaceuticals has expanded its Actimab-A patent portfolio while disclosing it is not currently compliant with two NYSE American continued listing standards. #Biotech #Health #Medicine Disclaimer: This is NOT a financial advice
Show PostBiomind Labs began trading on the CSE under BMND after leaving Cboe Canada. The venue change did not raise capital, while the company's latest filing says further clinical trials are largely on hold pending financing. biotechstockdaily.com/pharmaceutic... Disclaimer: This is NOT a financial advice
Show PostArkBio has received IND clearance from China's NMPA for AK0406, a long-acting antiviral designed for influenza prophylaxis, as Phase 1 testing continues in Australia. Disclaimer: This is NOT a financial advice
Show Post